FAQ  /  Women's Hormone Health

My primary says my testosterone is too high. Should I lower my dose?

Your primary flagged a high testosterone and may have warned about lasting side effects. That conversation is common, and it does not automatically mean your hormone plan is wrong. It means the two of you, along with your hormone clinician, need a careful read of when the blood was drawn, how you feel, and whether androgenic effects are showing up.

This page is written for women on testosterone therapy. Men with the same question will find the FAQs on hematocrit and blood donation and testosterone and blood clots more relevant.

Putting a "High" Flag in Context

---

A reference range tells a clinician whether a value is unusual compared with the population the lab serves. That makes it good at flagging possible disease. It was not built to define where an individual woman feels and functions best, and on a lab report "normal" usually means common, not optimal.

Many women find their symptoms resolve only when total testosterone sits above the lab's upper limit. The major consensus statements recommend keeping levels near the premenopausal range. That recommendation reflects the fact that long-term studies above that range have not yet been done, not evidence of harm there. Individualized dosing above the range is an area where clinical experience has moved ahead of the published trials, which is why monitoring side effects and blood counts matters.

Primary care is doing the right thing when a flagged value prompts a closer look. Hormone optimization asks a narrower follow-on question once disease has been reasonably excluded.

Why the Same Level Means Different Things in Different Women

---

Two women with the same testosterone level can have very different experiences. Sex hormone binding globulin (SHBG) varies widely from person to person and rises with oral estrogen. When SHBG is high, more testosterone is bound and inactive, so a higher total level is needed to reach an ordinary amount of free, active hormone.

Sensitivity at the androgen receptor also differs genetically. In healthy women, variation in the androgen receptor gene has been linked to how much hair growth a woman develops, independent of her testosterone level. Some women develop side effects at modest levels while others have none at levels well above the reference range, and the level at which symptoms improve varies just as much. This is why lab values inform dosing but cannot dictate it on their own.

Peak vs Trough, and Other Routes

---

With a weekly injection, levels are highest in the first days after the shot and lowest just before the next one. A draw taken early in the cycle can read "High" even when average exposure across the week is moderate, while a trough draw shows the floor. With creams and gels, timing relative to the daily application matters. Pellets tend to peak in the first several weeks after insertion and decline from there.

Whatever the route, knowing when the blood was drawn is what makes the number interpretable. Ask whether the lab was timed as a trough, a mid-interval check, or something else. More on timed monitoring is in the Testosterone in Women research guide.

Side Effects and the Shared Dose Decision

---

How you feel and function, and whether androgenic effects appear, are what drive dose decisions. Acne, oily skin, and new facial or body hair are usually the first signs that exposure is higher than you need, and they typically improve when the dose is lowered.

In clinical practice, voice change and clitoral enlargement tend to appear later, after those earlier signs have gone unaddressed and levels have stayed high for an extended period. When the dose is reduced at the first androgenic signs, those later changes are usually avoided. Voice and clitoral changes still deserve prompt attention on their own, because once established they may not fully reverse.

Hematocrit, the concentration of red blood cells, is also worth monitoring, especially with injections or pellets. It is an objective safety marker that does not depend on how you feel.

If you notice any change in your voice or clitoral size, contact the clinician managing your hormones promptly. Do not change your dose based on this article alone.

Two Lenses, One Patient

---

Primary care is trained to treat a value outside the population reference range as a reason to look for disease first. That is good general medicine. A dedicated hormone practice starts from a narrower question: once disease is reasonably ruled out, what exposure fits your symptoms and function, safely monitored?

Those lenses can disagree on the same printout without either clinician being careless. The useful step is a shared read of draw timing, symptoms, side effects, and goals.

What to Bring to the Conversation

---

Bring the following to the clinician managing your hormones:

• The lab printout.
• The draw timing relative to your injection, cream, or pellet.
• A list of symptoms, including any side effects and when they started.

— Dr. Darrell Wilcox · @wellnessdoc_4everyoung on Instagram